Citations

Mayo Clinic

Showing 10 of 108376 citations.

Short-term prednisone use antagonizes insulin's anabolic effect on muscle protein and glucose metabolism in young healthy people
Short, Kevin R. , Bigelow, Maureen L., Nair, K. Sreekumaran

American Journal of Physiology-Endocrinology and Metabolism | September 8, 2009 | Volume: 297 | Issue: 6 | Pages: E1260-E1268

10.1152/ajpendo.00345.2009 | PMID 19738036 Get It

Glucocorticoids cause muscle atrophy and weakness, but the mechanisms for these effects are unclear. The purpose of this study was to test a hypothesis that prednisone (Pred) counteracts insulin's anabolic effects on muscle. A randomized, double-blind cross-over design was used to test the effects of 6 days either Pred (0.8 mg·kg−1·day−1) or placebo use in seven healthy young volunteers. Protein dynamics were measured across the leg using stable isotope tracers of leucine (Leu) and phenylalanine (Phe) after overnight fast and during a hyperinsulinemic (1.5 μU·min−1·kg FFM−1) euglycemic clamp with amino acid replacement. Fasting glucose, amino acids, insulin, and glucagon were higher ( P < 0.01) on Pred vs. placebo, whereas leg blood flow was 18% lower. However, basal whole body and leg kinetics of Leu and Phe were unaltered by Pred. Insulin infusion increased leg glucose uptake in both trials but was 65% lower with Pred than with placebo. Insulin in both trials similarly suppressed whole body flux of Leu and Phe. Importantly, insulin increased net Leu and Phe balance across the leg and the balance between muscle protein synthesis and breakdown, but these changes were 45–140% lower ( P < 0.03) in Pred than in placebo. The present study demonstrates that short-term Pred use in healthy people does not alter whole body or leg muscle protein metabolism during the postaborptive state but causes muscle insulin resistance for both glucose and amino acid metabolism, with a blunted protein anabolism. This interactive effect may lead to muscle atrophy with continued use of glucocorticoids.
Manuscript Preparation and Publication
Holmes, David R. , Hodgson, Patricia, Nishimura, Rick A., Simari, Robert D.

Circulation | September 8, 2009 | Volume: 120 | Issue: 10 | Pages: 906-913

10.1161/circulationaha.107.752782 | PMID 19738151 Get It

Prevention of Progression in Monoclonal Gammopathy of Undetermined Significance
Rajkumar, S. Vincent , Rajkumar, S Vincent

Clinical Cancer Research | September 8, 2009 | Volume: 15 | Issue: 18 | Pages: 5606-5608

10.1158/1078-0432.ccr-09-1575 | PMID 19737944 Get It

Abstract Monoclonal gammopathy of undetermined significance (MGUS) is a common premalignant plasma cell proliferative disorder with a lifelong risk of progression to multiple myeloma. Because myeloma is an incurable malignancy, strategies to delay or prevent progression in high-risk patients are of considerable importance. (Clin Cancer Res 2009;15(18):5606–8)
MicroRNA Expression Signatures in Barrett's Esophagus and Esophageal Adenocarcinoma
Yang, Hushan , Gu, Jian , Wang, Kenneth K. , Zhang, Wei , Xing, Jinliang , Wu, Xifeng , Chen, Zhi‐Nan , Ajani, Jaffer A. , Gu, Jian

Clinical Cancer Research | September 8, 2009 | Volume: 15 | Issue: 18 | Pages: 5744-5752

10.1158/1078-0432.ccr-09-0385 | PMID 19737949 Get It

Abstract Purpose: Esophageal adenocarcinoma is a highly aggressive malignancy that frequently develops from Barrett's esophagus, a premalignant pathologic change occurring in the lower end of the esophagus. Identifying Barrett's esophagus patients at high risk of malignant transformation is essential to the prevention of esophageal adenocarcinoma. Although microRNA (miRNA) expression signatures have been associated with the etiology and prognosis of several types of cancers, their roles in the development of esophageal adenocarcinoma have not been extensively evaluated. Experimental Design: In this study, we analyzed the expression patterns of 470 human miRNAs using Agilent miRNA microarray in 32 disease/normal-paired tissues from 16 patients diagnosed with Barrett's esophagus of either low- or high-grade dysplasia, or esophageal adenocarcinoma. Results: Using unsupervised hierarchical clustering and class comparison analyses, we found that miRNA expression profiles in tissues of Barrett's esophagus with high-grade dysplasia were significantly different from their corresponding normal tissues. Similar findings were observed for esophageal adenocarcinoma, but not for Barrett's esophagus with low-grade dysplasia. The expression patterns of selected miRNAs were further validated using quantitative reverse transcription real-time PCR in an independent set of 75 pairs of disease/normal tissues. Finally, we identified several miRNAs that were involved in the progressions from low grade-dysplasia Barrett's esophagus to esophageal adenocarcinoma. Conclusions: We showed that miRNAs were involved in the development and progression of esophageal adenocarcinoma. The identified significant miRNAs that may become potential targets for early detection, chemoprevention, and treatment of esophageal cancer. (Clin Cancer Res 2009;15(18):5744–52)
ECMO Cannulation Controversies and Complications
Stulak, John M., Burkhart, Harold M. , Barnes, Roxann D., Scott, Phillip D., Schears, Gregory J. , Dearani, Joseph A.

Seminars in Cardiothoracic and Vascular Anesthesia | September 7, 2009 | Volume: 13 | Issue: 3 | Pages: 176-182

10.1177/1089253209347943 | PMID 19736214 Get It

Advances in extracorporeal life support have expanded indications for use extending beyond patients undergoing cardiac surgery. The approach to cannulation in patients requiring extracorporeal membrane oxygenation should be individualized and based on the specific clinical scenario in which the need arises. Adherence to proper techniques of vessel visualization, exposure, and cannulation along with accurate placement of cannulae will optimize flows and minimize complications in this setting. Patients in need of mechanical circulatory support require input from a multidisciplinary team approach with systematic clinical evaluation to optimize outcome. If hemodynamics do not initially permit the successful separation from mechanical support, then a systematic search for potentially reversible patient and/ or pump related factors should be undertaken. The success of this therapy is predicated on patient selection, a multidisciplinary team approach in the intensive care unit, adherence to precise technical principles, and repeated patient evaluation.
New Information in Our Evolving Understanding of Migraine Aura and Cortical Spreading Depression
Cutrer, F. Michael

Cephalalgia | September 7, 2009 | Volume: 29 | Issue: 10 | Pages: 1129-1131

10.1111/j.1468-2982.2009.01985.x | PMID 19735539 Get It

Reciprocal Human Dendritic Cell–Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus
Prestwich, Robin, Errington‐Mais, Fiona , Steele, Lynette P., Ilett, Elizabeth J. , Morgan, Ruth, Harrington, Kevin J. , Pandha, Hardev , Selby, Peter J. , Vile, Richard G. , Melcher, Alan , Ilett, Elizabeth J , Errington-Mais, Fiona , Melcher, Alan A , Harrington, Kevin

The Journal of Immunology | September 5, 2009 | Volume: 183 | Issue: 7 | Pages: 4312-4321

10.4049/jimmunol.0901074 | PMID 19734207 Get It

Abstract Oncolytic virotherapy may mediate antitumor effects via direct oncolysis or immune-mediated tumor regression. Although the ability of oncolytic viruses to generate adaptive antitumor immunity has been characterized, their interactions with the innate immune system are relatively unclear. Using a human in vitro system, this study investigates the innate immunological consequences of reovirus therapy and its potential to activate NK cell-mediated antitumor activity. Dendritic cells (DC) loaded with reovirus-infected human melanoma Mel888 cells (DC-MelReo), but not reovirus-infected tumor cells alone, induced IFN-γ production within the NK cell population upon coculture with PBMC, in a cell-to-cell contact-dependent manner. DC-MelReo secreted the chemokines CCL2, 3, 4, 5, 7, 8, 11, and CXCL10; these culture supernatants induced NK cell chemotaxis. Coculture of DC-MelReo with purified NK cells induced reciprocal contact-dependent phenotypic DC maturation, while DC-MelReo elicited up-regulation of the activation marker CD69 on NK cells, in a partially contact and partially IL-12 dependent manner. Significantly, DC-MelReo induced NK cell cytotoxicity toward tumor cells by a type I IFN dependent mechanism. These data demonstrate that tumor infection by reovirus can act via DC to induce NK cell recruitment, activation, and cytotoxicity, along with reciprocal DC maturation. These findings suggest that reciprocal DC-NK cell interactions, following reovirus therapy, may play an important role in altering the immune milieu of the tumor microenvironment and mediating tumor regression.
Adapting the Sheehan Disability Scale to Assess Child and Parent Impairment Related to Childhood Anxiety Disorders
Whiteside, Stephen P. H.

Journal of Clinical Child & Adolescent Psychology | September 4, 2009 | Volume: 38 | Issue: 5 | Pages: 721-730

10.1080/15374410903103551 | PMID 20183656 Get It

Comonitoring of adenosine and dopamine using the Wireless Instantaneous Neurotransmitter Concentration System: proof of principle
Chang, Su-Youne , Tye, Susannah J. , Kimble, Christopher J., Bennet, Kevin E. , Blaha, Charles D. , Lee, Kendall H. , Shon, Young‐Min , Tye, Susannah J , Blaha, Charles

Journal of Neurosurgery | September 4, 2009 | Volume: 112 | Issue: 3 | Pages: 539-548

10.3171/2009.7.jns09787 | PMID 19731995 Get It

Object The authors of previous studies have demonstrated that local adenosine efflux may contribute to the therapeutic mechanism of action of thalamic deep brain stimulation (DBS) for essential tremor. Real-time monitoring of the neurochemical output of DBS-targeted regions may thus advance functional neurosurgical procedures by identifying candidate neurotransmitters and neuromodulators involved in the physiological effects of DBS. This would in turn permit the development of a method of chemically guided placement of DBS electrodes in vivo. Designed in compliance with FDA-recognized standards for medical electrical device safety, the authors report on the utility of the Wireless Instantaneous Neurotransmitter Concentration System (WINCS) for real-time comonitoring of electrical stimulation–evoked adenosine and dopamine efflux in vivo, utilizing fast-scan cyclic voltammetry (FSCV) at a polyacrylonitrile-based (T-650) carbon fiber microelectrode (CFM). Methods The WINCS was used for FSCV, which consisted of a triangle wave scanned between −0.4 and +1.5 V at a rate of 400 V/second and applied at 10 Hz. All voltages applied to the CFM were with respect to an Ag/AgCl reference electrode. The CFM was constructed by aspirating a single T-650 carbon fiber (r = 2.5 μm) into a glass capillary and pulling to a microscopic tip using a pipette puller. The exposed carbon fiber (the sensing region) extended beyond the glass insulation by ~ 50 μm. Proof of principle tests included in vitro measurements of adenosine and dopamine, as well as in vivo measurements in urethane-anesthetized rats by monitoring adenosine and dopamine efflux in the dorsomedial caudate putamen evoked by high-frequency electrical stimulation of the ventral tegmental area and substantia nigra. Results The WINCS provided reliable, high-fidelity measurements of adenosine efflux. Peak oxidative currents appeared at +1.5 V and at +1.0 V for adenosine, separate from the peak oxidative current at +0.6 V for dopamine. The WINCS detected subsecond adenosine and dopamine efflux in the caudate putamen at an implanted CFM during high-frequency stimulation of the ventral tegmental area and substantia nigra. Both in vitro and in vivo testing demonstrated that WINCS can detect adenosine in the presence of other easily oxidizable neurochemicals such as dopamine comparable to the detection abilities of a conventional hardwired electrochemical system for FSCV. Conclusions Altogether, these results demonstrate that WINCS is well suited for wireless monitoring of high-frequency stimulation-evoked changes in brain extracellular concentrations of adenosine. Clinical applications of selective adenosine measurements may prove important to the future development of DBS technology.
Candidate Gene Polymorphisms for Ischemic Stroke
Matarín, Mar, Brown, W. Mark , Dena, Hernandez, Britton, Angela, Vrieze, Fabienne Wavrant De, Brott, Thomas G. , Brown, Robert D., Worrall, Bradford B. , Case, L. Douglas, Metter, E. Jeffrey , Gamble, Dale M., Hardy, John , Rich, Stephen S. , Singleton, Andrew , Chanock, Stephen Jacob , Ferrucci, Luigi , Meschia, James F. , Rich, Stephen S , Hardy, John

Stroke | September 4, 2009 | Volume: 40 | Issue: 11 | Pages: 3436-3442

10.1161/strokeaha.109.558015 | PMID 19729601 Get It

Background and Purpose— Ischemic stroke (IS) is a multifactorial disorder with strong evidence from twin, family, and animal model studies suggesting a genetic influence on risk and prognosis. Several candidate genes for IS have been proposed, but few have been replicated. We investigated the contribution of 67 candidate genes (369 single nucleotide polymorphisms [SNPs]) on the risk of IS in a North American population of European descent. Methods— Two independent studies were performed. In the first, 342 SNPs from 52 candidate genes were genotyped in 307 IS cases and 324 control subjects. The SNPs significantly associated with IS were tested for replication in another cohort of 583 IS cases and 270 control subjects. In the second study, 212 SNPs from 62 candidate genes were analyzed in 710 IS cases with subtyping available and 3751 control subjects. Results— None of the candidate genes (SNPs) were significantly associated with IS risk independent of known stroke risk factors after correction for multiple hypotheses testing. Conclusion— These results are consistent with previous meta-analyses that demonstrate an absence of genetic association of variants in plausible candidate genes with IS risk. Our study suggests that the effect of the investigated SNPs may be weak or restricted to specific populations or IS subtypes.